Sentences with phrase «granting program at»

You must also be enrolled full - time, or at least «half time», in a degree granting program at an eligible college or university.
Citizens Bank Student Loan Eligibility: Borrowers must be enrolled at least half - time in a degree - granting program at an eligible institution.
The student whose education expenses will be paid for with the loan proceeds must be a U.S. citizen or permanent resident and must be enrolled at least half - time in a degree granting program at a Citizens Bank - participating school.
Borrowers must be enrolled at least half - time in a degree - granting program at an eligible institution.
College Enrollment: Be enrolled at least half - time in a degree - granting program at an eligible institution
The student whose education expenses will be paid for with the loan proceeds must be a U.S. citizen or permanent resident and must be enrolled at least half - time in a degree granting program at a Citizens One participating school.
Borrowers must be enrolled at least half - time in a degree - granting program at an eligible institution.
If elected, Faso has proposed to establish a competitive grant program at the federal level to fund qualified nonprofits that provide peer - to - peer counseling services to veterans suffering from PTSD, TBI and other trauma.
Agree to sponsor a public hearing on the 2013 Rockland County Community Development Block Grant Program at 8 p.m. on January 29 at the Town Hall.
The Senate Standing Committee on Social Services will host a public hearing regarding the Community Services Block Grant Program at the Legislative Office Building, 10:00 a.m.
These numbers were sufficient to convince APS to continue the grant program at its own expense, with several APS divisions jumping onboard.
But that didn't stop Culberson from saying he would bolster several programs within the subcommittee's purview — not just NSF's research account, but also the aeronautics program at NASA, the Legal Services Corporation, and the Sea Grant program at the National Oceanic and Atmospheric Administration.
«The wind was blowing 30 miles [48 kilometers] per hour this morning,» says Arnold Boezaart, vice president for grant programs at the Community Foundation for Muskegon County, whose four - story arts complex boasts the first commercial SWIFT attached to a mast jutting from its outside wall.
«But you can count on one hand the number of studies that have been done on what people actively do with the disposal of PPCPs — pharmaceutical and personal care products — for both themselves and their pets,» said Sam Chan, a watershed health expert with the Oregon Sea Grant program at Oregon State.
Katie Engen Katie manages the Education and Outreach initiatives including several grant programs at the American Society of Plant Biologists (ASPB).
They share concerns that President Obama's FY13 budget request emphasizes funding for new competitive grant programs at the expense of investments in cornerstone federal K — 12 programs like Title I and the Individuals with Disabilities Education Act (IDEA).
In today's ENR: Standard looks at the Student Success Grant Program at Roy High.
They also discuss what role U.S. Secretary of Education nominee Betsy Devos plays in the state's school closure discussion, concerns over President Donald Trump's order to freeze all grant programs at the U.S. Environmental Protection Agency, and a move to bring new voting machines to Michigan.
For fiscal year 2004, the General Assembly recommends funding the Student Achievement Grants program at a decreased amount (equal to the existing amount of funding for Dropout Prevention of $ 10.1 million) eliminating the portion of funding that was to come from the School Health Incentive program and the Technology Resource Assistants program.
Join the Abbot Kinney Community for the 2nd Annual Craw Fest and support the AKFA Community Grants Program at the same time!
Proceeds raised at this fun event will go directly to the Teacher Innovation Grant Program at Lane Tech.

Not exact matches

«We have dramatically increased access to school options for Newark families, provided grants directly to teachers at 37 schools, given 300,000 books to Newark students through the My Very Own Library program, and just recently, we committed to a $ 1 million initiative to improve early childhood education in Newark,» the foundation said in a statement to CNBC.
For those non-white male students accepted into the program — there is an application process — Lazard grants them $ 30,000 at first and then another $ 45,000 if they are offered an accept a full - time position at the firm.
Fliegel eventually studied government and legal studies at Bowdoin — and, in his senior year, won the Jefferson Davis Book Award, granted to the top student in the program.
Eduventures says about one million students are enrolled in degree - granting online programs this year at both traditional schools and at for - profit programs such as the University of Phoenix.
Genentech 100 Best Companies rank: 11 At Genentech all exempt employees and hourly workers who put in at least 20 hours per week are eligible for the company's Long Term Incentive program and receive the grants as part of their overall compensation packagAt Genentech all exempt employees and hourly workers who put in at least 20 hours per week are eligible for the company's Long Term Incentive program and receive the grants as part of their overall compensation packagat least 20 hours per week are eligible for the company's Long Term Incentive program and receive the grants as part of their overall compensation package.
The temporary foreign worker program was first under fire in the fall of 2012, when it came to light that approval was granted to Chinese - owned HD Mining International to bring more than 200 people from China to work at its coal mine near Tumbler Ridge, B.C.
These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (tprograms; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (tPrograms (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (tprograms; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).
The program, called Mission Main Street Grants, is open to businesses that have been open for at least two years and have less than 100 full - time, year - round employees.
The budget also proposes block granting Medicaid and the Children's Health Insurance Program (CHIP) at pre-ACA levels along with a state option of per - capita cap funding.
Bank of America has been hit with a proposed class action by a Brazilian citizen who said he was denied a job at the bank because his work authorization, granted under the Deferred Action for Childhood Arrivals, or DACA program, is subject to renewal.
The IPT grant program is a competitive grant program focusing on innovative and effective investor education and protection programs delivered at the local, State and regional level.
In August 2012, to create incentives for continued long - term success from the then - recently launched Model S program as well as from Tesla's then - planned Model X and Model 3 programs, and to further align executive compensation with increases in stockholder value, the Board granted to Mr. Musk a stock option award to purchase 5,274,901 shares of Tesla's common stock (the «2012 CEO Performance Award»), representing 5 % of Tesla's total issued and outstanding shares at the time of grant.
The proceeds of the conference will go to support programs and chapters at the local level throughout the United States (we've also put up a $ 50,000 matching grant to encourage donations).
Commencing in 2011, this three - year, AUD 12 M program was led by Myriota Founders, Dr Alex Grant and Dr David Haley, at UniSA's Institute for Telecommunications Research.
The grant was awarded to teams of researchers at Ryerson University and California Lutheran University who looked at a wide range of assistance programs targeting branding, financing, and management - associated challenges, among other issues.
November 28, 2017 — Vancouver, BC — Japan Gold Corp. (TSX - V: JG)(OTCQB: JGLDF)(«Japan Gold» or the «Company») is pleased to announce that it has been granted a drilling permit for the Akebono prospect at the Company's Ikutahara Project in Hokkaido, Japan, and the drilling program has commenced.
A drilling permit was granted and the Company's first scout drilling program was completed at the Akebono prospect in December 2017.
NEWS RELEASE November 28, 2017 — Vancouver, BC — Japan Gold Corp. (TSX - V: JG)(OTCQB: JGLDF)(«Japan Gold» or the «Company») is pleased to announce that it has been granted a drilling permit for the Akebono prospect at the Company's Ikutahara Project in Hokkaido, Japan, and the drilling program has commenced.
11-18-2005 2005 Drilling Program Completed on Caledonia's Mulonga Plain Joint Venture 11-14-2005 Caledonia Mining 3rd Quarter Results 2005 10-13-2005 Available online: Webcast of presentation to the Minesite Forum 10-11-2005 London: Presentation to the Minesite Forum 09-14-2005 Caledonia amends terms of share purchase warrants 09-13-2005 Caledonia and Motapa announce 11 drill targets at Mulonga Plain Kashiji Plain analytical results confirm possible local source 08-15-2005 Caledonia Mining signs a Memorandum of Understanding with a South African Black Economic Empowerment Consortium 08-12-2005 Caledonia Mining Second Quarter Results 2005 08-11-2005 Caledonia Mining Second Quarter Results Conference Call and Webcast 07-18-2005 Caledonia announces Summer Drilling Program on Kikerk Lake Property, Nunavut 06-22-2005 Caledonia Mining Corporation announces Admission to the AIM Market of the London Stock Exchange and # 1.57 million placing 06-13-2005 Caledonia Mining signs a Letter of Intent with a Cobalt Refinery to supply 3 % of total annual world production 05-16-2005 Caledonia Mining 1st Quarter Results 2005 05-06-2005 Caledonia Annual Meeting set for Tuesday May 10th 2005 05-05-2005 Caledonia Mining Granted Prospecting Right for Grasvally and Will Commence the Drilling Program by Mid May 2005 03-29-2005 Caledonia Mining 4th Quarter and 2004 Annual Results 03-23-2005 Caledonia Mining Fourth Quarter and Annual results Conference call & webcast 03-08-2005 Mulonga Plain JV Exploration Work Program Update 02-23-2005 Caledonia Mining Appoints New Chairman 01-31-2005 Caledonia updates diamond exploration results at Mulonga Plain joint venture in Zambia.
A drilling permit has been granted and the Company's first scout drilling program was completed at the Akebono prospect at the Ikutahara Project in December 2017.
New York Stock Exchange — May 20, 2016 After receiving overwhelming support for its compensation program in the wake of substantial structural and disclosure - related changes announced ahead of the Company's 2015 annual meeting, shareholders must now consider whether these structural features, however robust, can ultimately be expected to reign in compensation that is routinely granted at levels far exceeding peer levels.
Schachter recently created a foundation called Safe Schools for Alex, which is raising money at SafeSchoolsForAlex.org for grants to assist schools in updating their safety programs.
Despite having healthy supports in place at both the Federal and Provincial programming levels, in the form of R&D tax credits, grants, loans and collaborative agreements, it's our ability to grow Canada's R&D - intensive sectors that proves weak.
«In the 2012 budget there are a number of items that just seem to be quite frankly at odds with Catholic social teachings in this regard - the cuts that he makes to WIC [women, infants and children] programs, the 20 % cuts in food stamps, cuts to maternal and infant grants.
If SB 1146 were to pass, it would deny students» ability to participate in state grant programsprograms that exist to help low - income students, and which are overwhelmingly used by racial minorities — at schools that are found in violation of the bill.
At the national level, the Empowerment Zone / Enterprise Community program awards block grants to foster local collaboration, and tax incentives to encourage private sector investment,
More information about the grant program can be found at BrewersAssociation.org.
At the silver anniversary of its global packaging awards program, DuPont granted top honors to U.K. - based design firm pi global for AidPod, which delivers life - saving medicine to remote sub-Saharan villages.
The American Beverage Foundation for a Healthy America seeks to make a significant contribution to the health of local communities by providing grants to support charitable programs at community organizations that work to advance both the physical health of their local citizens and the environmental health of their communities.
a b c d e f g h i j k l m n o p q r s t u v w x y z